Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients

NCT04261777 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
172
Enrollment
INDUSTRY
Sponsor class

Stopped The study was closed prematurely in order to finalise it under EU directive 2001/20/EC, without transitioning to EU-CTR, and avoiding unnecessary delay of the marketing authorisation application.

Conditions

Interventions

Sponsor

Saving Patients' Lives Medical B.V.

Collaborators